Citations (103)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Helge L. Waldum. (2020) Clinical consequences of controversies in gastric physiology. Scandinavian Journal of Gastroenterology 55:6, pages 752-758.
Read now
Read now
Pentti Sipponen & Heidi-Ingrid Maaroos. (2015) Chronic gastritis. Scandinavian Journal of Gastroenterology 50:6, pages 657-667.
Read now
Read now
Wouter J den Hollander & Ernst J Kuipers. (2012) Current pharmacotherapy options for gastritis. Expert Opinion on Pharmacotherapy 13:18, pages 2625-2636.
Read now
Read now
Pentti Sipponen & David Y. Graham. (2007) Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: Application of plasma biomarkers. Scandinavian Journal of Gastroenterology 42:1, pages 2-10.
Read now
Read now
Hilpi Rautelin & Timo Kosunen. (2004) Helicobacter pylori infection in Finland. Annals of Medicine 36:2, pages 82-88.
Read now
Read now
M. Oona, T. Rägo & H.-I. Maaroos. (2004) Long-term recurrence rate after treatment of Helicobacter pylori infection in children and adolescents in Estonia. Scandinavian Journal of Gastroenterology 39:12, pages 1186-1191.
Read now
Read now
T. Suzuki, K. Ina, T. Nishiwaki, T. Tsuzuki, T. Okada, R. Furuta, K. Nobata, T. Ando, K. Kusugami & H. Goto. (2004) Differential roles of interleukin‐1β and interleukin‐8 in neutrophil transendothelial migration in patients with Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 39:4, pages 313-321.
Read now
Read now
T. Matysiak-Budnik, A. de Mascarel, M. Abely, K. Mayo, M. Heyman, F. Mégraud. (2000) Positive Effect of Rebamipide on Gastric Permeability in Mice after Eradication of Helicobacter felis. Scandinavian Journal of Gastroenterology 35:5, pages 470-475.
Read now
Read now
O. Gutierrez, M. Melo, A. M. Segura, A. Angel, R. M. Genta & D. Y. Graham. (1997) Cure of Helicobacter pylori Infection Improves Gastric Acid Secretion in Patients with Corpus Gastritis. Scandinavian Journal of Gastroenterology 32:7, pages 664-668.
Read now
Read now
P. Unge & A. Berstad. (1996) Pooled Analysis of Anti-Helicobacter pylori Treatment Regimens. Scandinavian Journal of Gastroenterology 31:sup220, pages 27-40.
Read now
Read now
P. Unge. (1996) Review of Helicobacter pylori Eradication Regimens. Scandinavian Journal of Gastroenterology 31:sup215, pages 74-81.
Read now
Read now
D. Armstrong. (1996) Helicobacter pylori Infection and Dyspepsia. Scandinavian Journal of Gastroenterology 31:sup215, pages 38-47.
Read now
Read now
S. Miehlke, E. Bayerdörffer, N. Lehn, G. A. Mannes, A. Sommer, W. Höchter, J. Weingart, E. Bästlein, R. Hatz & M. Stolte. (1996) Severity of Helicobacter pylori Gastritis Predicts Duodenal Ulcer Recurrence. Scandinavian Journal of Gastroenterology 31:9, pages 856-862.
Read now
Read now
Timo U. Kosunen. (1995) Antibody Titres in Helicobacter pylori Infection: Implications in the Follow-up of Antimicrobial Therapy. Annals of Medicine 27:5, pages 605-607.
Read now
Read now
J. S. Dixon. (1995) Helicobacter pylori Eradication: Unravelling the Facts. Scandinavian Journal of Gastroenterology 30:sup212, pages 48-62.
Read now
Read now
S. Niemelä, T. Karttunen & T. Kerola. (1995) Helicobacter pylori-Associated Gastritis Evolution of Histologic Changes over 10 Years. Scandinavian Journal of Gastroenterology 30:6, pages 542-549.
Read now
Read now
R. J. Adamek, M. Freitag, W. Opferkuch, G. H. Rühl & M. Wegener. (1994) Intravenous Omeprazole/Amoxicillin and Omeprazole Pretreatment in Helicobacter pylori-Positive Acute Peptic Ulcer Bleeding: A Pilot Study. Scandinavian Journal of Gastroenterology 29:10, pages 880-883.
Read now
Read now
G. N. J. Tytgat. (1994) Long-Term Consequences of Helicobacter pylori Eradication. Scandinavian Journal of Gastroenterology 29:sup205, pages 38-44.
Read now
Read now
M. Ashorn, T. Ruuska, R. Karikoski, A. Miettinen & M. Maki. (1994) A Long-Term Follow-up after Treatment with Colloidal Bismuth Subcitrate and Tinidazole. Scandinavian Journal of Gastroenterology 29:3, pages 203-208.
Read now
Read now
J. C. Thijs, A. A. Van Zwet & H. B. Oey. (1993) Efficacy and Side Effects of a Triple Drug Regimen for the Eradication of Helicobacter pylori. Scandinavian Journal of Gastroenterology 28:11, pages 934-938.
Read now
Read now
K. Seppala, M. Farkkila, H. Nuutinen, K. Hakala, H. Väänänen, H. Rautelin & T. U. Kosunen. (1992) Triple Therapy of Helicobacter pylori Infection in Peptic Ulcer: A 12-Month Follow-up Study of 93 Patients. Scandinavian Journal of Gastroenterology 27:11, pages 973-976.
Read now
Read now
Articles from other publishers (82)
Kim VaipheiKim Vaiphei. 2022. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond
77
90
.
Juntao Kan, Junrui Cheng, Leiming Xu, Molly Hood, Dingfu Zhong, Meijiao Cheng, Yumin Liu, Liang Chen & Jun Du. (2019) The combination of wheat peptides and fucoidan protects against chronic superficial gastritis and alters gut microbiota: a double-blinded, placebo-controlled study. European Journal of Nutrition 59:4, pages 1655-1666.
Crossref
Crossref
Pradeep K. Siddappa & John W. Birk. 2019. Healthy Aging. Healthy Aging
67
79
.
Luca Formichella, Laura Romberg, Hannelore Meyer, Christian Bolz, Michael Vieth, Michael Geppert, Gereon Göttner, Christina Nölting, Wolfgang Schepp, Arne Schneider, Kurt Ulm, Petra Wolf, Ingrid Lisanne Holster, Ernst J. Kuipers, Bernd Birkner, Erwin Soutschek & Markus Gerhard. (2017)
Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting
Helicobacter pylori
Strain and Eradication Status
. Journal of Immunology Research 2017, pages 1-10.
Crossref
Crossref
Kevin Sze-Hang Liu. (2016)
Helicobacter pylori
associated gastric intestinal metaplasia: Treatment and surveillance
. World Journal of Gastroenterology 22:3, pages 1311.
Crossref
Crossref
Hala El‐Zimaity & Robert H. Riddell. 2013. Morson and Dawson's Gastrointestinal Pathology. Morson and Dawson's Gastrointestinal Pathology
110
161
.
Tae Ho KimSok Won Han. (2013) Atrophic Gastritis: Reversible after Treatment?. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 13:1, pages 25.
Crossref
Crossref
Maiko Furukawa, Mikiko Fujita, Akira Takinishi, Ryoichi Misaka & Hikaru Nagahara. (2011) Low-dose Aspirin Delays Gastric Healing after Helicobacter pylori Eradication. Internal Medicine 50:9, pages 951-959.
Crossref
Crossref
Peter Malfertheiner. (2011) Gastric Atrophy Reversible or Irreversible after <i>Helicobacter pylori</i> Eradication – An Open Question. Digestion 83:4, pages 250-252.
Crossref
Crossref
D. Scott Merrell. 2009. Bacterial-Epithelial Cell Cross-Talk. Bacterial-Epithelial Cell Cross-Talk
327
355
.
Xiao-Hui Huo. (2006) Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients. World Journal of Gastroenterology 12:19, pages 3105.
Crossref
Crossref
FRANCESCO DI MARIO, ALI M MOUSSA, NADIA DAL BO, PIETRO CARUANA, ALBERTO PILOTTO, LUCAS G CAVALLARO, GIULIA M CAVESTRO, VERONICA IORI, ROBERTA MERLI, ANGELO FRANZE & MASSIMO RUGGE. (2005) Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: Prospective 4-year study. Journal of Gastroenterology and Hepatology 20:11, pages 1661-1666.
Crossref
Crossref
Kazushi Sakurai, Toshihiro Osaka & Katsuya Yamasaki. (2005) Rebamipide Reduces Recurrence of Experimental Gastric Ulcers: Role of Free Radicals and Neutrophils. Digestive Diseases and Sciences 50:S1, pages S90-S96.
Crossref
Crossref
Javier P. Gisbert & Josep M. Piqué. (2005) Indicaciones y consecuencias de la erradicación de Helicobacter pylori en la enfermedad por reflujo gastroesofágico. Medicina Clínica 124:18, pages 697-709.
Crossref
Crossref
Casmir Wambura, Nobuo Aoyama, Daisuke Shirasaka, Kohei Kuroda, Shuji Maekawa, Shigeyuki Ebara, Yoshinori Watanabe, Takao Tamura & Masato Kasuga. (2004) Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 16:10, pages 969-979.
Crossref
Crossref
T. Ohkusa, H. Miwa, T. Nomura, D. Asaoka, A. Kurosawa, N. Sakamoto, S. Abe, M. Hojo, T. Terai, T. Ogihara & N. Sato. (2004)
Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of
Helicobacter pylori
: comparison with H. pylori-negative patients
. Alimentary Pharmacology & Therapeutics 20, pages 25-32.
Crossref
Crossref
T. T. Koivisto, H. I. Rautelin, M. E. Voutilainen, S. E. Niemelä, M. Heikkinen, P. I. Sipponen & M. A. Färkkilä. (2004) Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population. Alimentary Pharmacology & Therapeutics 19:9, pages 1009-1017.
Crossref
Crossref
T. Fujioka, T. Arakawa, T. Shimoyama, T. Yoshikawa, M. Itoh, M. Asaka, H. Ishii, H. Kuwayama, R. Sato, S. Kawai, T. Takemoto & K. Kobayashi. (2003)
Effects of rebamipide, a gastro-protective drug on the
Helicobacter pylori
status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial
. Alimentary Pharmacology & Therapeutics 18, pages 146-152.
Crossref
Crossref
David A Owen. (2003) Gastritis and Carditis. Modern Pathology 16:4, pages 325-341.
Crossref
Crossref
X. Calvet & E. Gené. (2003) Erradicar Helicobacter pylori.¿Terapia triple o cuádruple?, ¿corta o larga?. Gastroenterología y Hepatología 26:5, pages 325-329.
Crossref
Crossref
David W. Day, Jeremy R. Jass, Ashley B. Price, Neil A. Shepherd, James M. Sloan, Ian C. Talbot, Bryan F. Warren & Geraint T. Williams. 2003. Morson and Dawson's Gastrointestinal Pathology. Morson and Dawson's Gastrointestinal Pathology
104
140
.
M. Hojo, H. Miwa, T. Ohkusa, R. Ohkura, A. Kurosawa & N. Sato. (2002)
Alteration of histological gastritis after cure of
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 16:11, pages 1923-1932.
Crossref
Crossref
T. Tomita, Y. Fukuda, K. Tamura, J. Tanaka, N. Hida, T. Kosaka, K. Hori, T. Sakagami, M. Satomi & T. Shimoyama. (2002)
Successful eradication of
Helicobacter pylori
prevents relapse of peptic ulcer disease
. Alimentary Pharmacology & Therapeutics 16, pages 204-209.
Crossref
Crossref
A. Kokkola, P. Sipponen, H. Rautelin, M. Härkönen, T. U. Kosunen, R. Haapiainen & P. Puolakkainen. (2002)
The effect of
Helicobacter pylori
eradication on the natural course of atrophic gastritis with dysplasia
. Alimentary Pharmacology & Therapeutics 16:3, pages 515-520.
Crossref
Crossref
Javier P. Gisbert, Xavier Calvet, Rafael Gabriel & José María Pajares. (2002) Infección por helicobacter pylori y dispepsia funcional. metaanálisis de la eficacia del tratamiento erradicador. Medicina Clínica 118:11, pages 405-409.
Crossref
Crossref
L. A. Fischbach, P. Correa, H. Ramirez, J. L. Realpe, T. Collazos, B. Ruiz, L. E. Bravo, J. C. Bravo, A. L. Casabon & B. A. Schmidt. (2002) Anti‐inflammatory and tissue‐protectant drug effects: results from a randomized placebo‐controlled trial of gastritis patients at high risk for gastric cancer. Alimentary Pharmacology & Therapeutics 15:6, pages 831-841.
Crossref
Crossref
R.H. Hunt, K. Sumanac & J.-Q. Huang. (2001)
Review article: should we kill or should we save
Helicobacter pylori
?
. Alimentary Pharmacology & Therapeutics 15, pages 51-59.
Crossref
Crossref
Tadhg Ó Cróinı́n, Marguerite Clyne, Ben J. Appelmelk & Brendan Drumm. (2001)
Antigastric Autoantibodies in Ferrets Naturally Infected with
Helicobacter mustelae
. Infection and Immunity 69:4, pages 2708-2713.
Crossref
Crossref
Arianna Gonelli, Sergio Boccia, Michela Boni, Alessandro Pozzoli, Caterina Rizzo, Patrizia Querzoli, Enzo Cassai & Dario Di Luca. (2001) Human herpesvirus 7 is latent in gastric mucosa. Journal of Medical Virology 63:4, pages 277-283.
Crossref
Crossref
V. De Francesco, A. Zullo, V. Rinaldi, C. Hassan, P. Ballanti, S. Winn, F. Diana, S. Morini & A.F. Attili. (2000) Relationship between antral lymphocyte density and basal gastrin levels in patients with Helicobacter pylori infection. Digestive and Liver Disease 32:8, pages 676-681.
Crossref
Crossref
A. Zullo, V. Rinaldi, C. Hassan, F. Diana, S. Winn, G. Castagna & A. F. Attili. (2001) Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study. Alimentary Pharmacology & Therapeutics 14:10, pages 1303-1309.
Crossref
Crossref
J. Martínek, L. Kužela, J. Špičák & A. Vavrečka. (2001)
Review article: the clinical influence of
Helicobacter pylori
in effective acid suppression—implications for the treatment of gastro‐oesophageal reflux disease
. Alimentary Pharmacology & Therapeutics 14:8, pages 979-990.
Crossref
Crossref
Angelo Zullo, Vittorio Rinaldi, Cesare Hassan, Franco Taggi, Marco Giustini, Simon Winn, Giancarlo Castagna & Adolfo F. Attili. (2000) Clinical and Histologic Predictors of Helicobacter pylori Infection Recurrence. Journal of Clinical Gastroenterology 31:1, pages 38-41.
Crossref
Crossref
Hans‐Gerd Dammann, Ulrich R. Fölsch, Eckhart G. Hahn, Detlef‐Hasso Von Kleist, Hans‐Ulrich Klör, Thomas Kirchner, Sonja Strobel & Manfred Kist. (2001)
Eradication of
H. pylori
with Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head‐to‐Head Comparison Between Two Regimens of Different Duration
. Helicobacter 5:1, pages 41-51.
Crossref
Crossref
I. Happonen, J. Linden & E. Westermarck. (2000) Effect of triple therapy on eradication of canine gastric helicobacters and gastric disease. Journal of Small Animal Practice 41:1, pages 1-6.
Crossref
Crossref
J.P. Gisbert, M. Blanco & J.M. Pajares. (2000) Efecto de la erradicación de Helicobacter pylori sobre las lesiones histológicas de la mucosa gástrica a lo largo de 18 meses. Revista Clínica Española 200:9, pages 480-484.
Crossref
Crossref
Bayerdörffer, Lonovics, Dité, Díete, Domján, Kisfalvi, Mégraud, Pap, Sipponen, Burman & Zeijlon. (2001)
Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 13:12, pages 1639-1645.
Crossref
Crossref
Seiichi Kato, Noriko FuruyamaKyoko Ozawa, Kenji Ohnuma & Kazuie Iinuma. (1999)
Long-term Follow-up Study of Serum Immunoglobulin G and Immunoglobulin A Antibodies After
Helicobacter pylori
Eradication
. Pediatrics 104:2, pages e22-e22.
Crossref
Crossref
S. P. Vyas & V. Sihorkar. (1999) Exploring novel vaccines against Helicobacter pylori: protective and therapeutic immunization. Journal of Clinical Pharmacy and Therapeutics 24:4, pages 259-272.
Crossref
Crossref
Hirohumi Ishikawa, Harunobu Ito, Masahide Higaki, Mika Higaki, Yoshimi Matsumoto, Toshiaki Kamimura, Yousuke Katsura, Tetsuo Tomishi, Yoshikazu Inoue, Hisashi Takasugi, Masaaki Tomoi, Steven Krakowka & Keizo Yoshida. (1999) FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities. European Journal of Pharmacology 378:3, pages 299-310.
Crossref
Crossref
Bojan Tepe?Boris Kav?i?Lijana K. Zaletel, Marija Gubina, Alojz Ihan, Mario Poljak & Igor Kri?man. (1999) Two- to four-year histological follow-up of gastric mucosa afterHelicobacter pylori eradication. The Journal of Pathology 188:1, pages 24-29.
Crossref
Crossref
Wangxue Chen, Dairu Shu, Ian R Wilson, Andy Tie & Vint Chadwick. (2002)
Rapid elimination of
Helicobacter pylori
and reduction of histocompatibility leucocyte antigen‐DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy
. Journal of Gastroenterology and Hepatology 14:4, pages 322-327.
Crossref
Crossref
Wermeille, Cunningham, Armenian, Zelger, Buri, Merki & Hadengue. (2001)
Failure of a 1‐day high‐dose quadruple therapy for cure of
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 13:2, pages 173-177.
Crossref
Crossref
J. Kalantar, G. D. Eslick & N. J. Talley. 1999. Gastroduodenal Disease and Helicobacter pylori. Gastroduodenal Disease and Helicobacter pylori
31
45
.
P. Unge. 1999. Gastroduodenal Disease and Helicobacter pylori. Gastroduodenal Disease and Helicobacter pylori
261
300
.
Takafumi Ando, Kazuo Kusugami, Masahiro Ohsuga, Kenji Ina, Masataka Shinoda, Toshihiro Konagaya, Tetsu Sakai, Akira Imada, Naomi Kasuga, Toshi Nada, Satoshi Ichiyama & Martin J. Blaser. (1998)
Differential Normalization of Mucosal Interleukin-8 and Interleukin-6 Activity after
Helicobacter pylori
Eradication
. Infection and Immunity 66:10, pages 4742-4747.
Crossref
Crossref
Romuald J. Adamek, Boris Pfaffenbach & Christian Szymanski. (2001)
Cure of
H. pylori
Infection Using a 7‐Day Triple Therapy Combining Pantoprazole with Two Antibiotics
. Helicobacter 3:3, pages 206-211.
Crossref
Crossref
J. Raymond, N. Kalach, M. Bergeret, P. H. Benhamou, J. P. Barbet, D. Gendrel & C. Dupont. (1998)
Effect of Metronidazole Resistance on Bacterial Eradication of
Helicobacter pylori
in Infected Children
. Antimicrobial Agents and Chemotherapy 42:6, pages 1334-1335.
Crossref
Crossref
N. Ectors, A. Driessen & K. Geboes. (1998) Réversibilité des lésions histologiquesReversibility of histological lesions. Acta Endoscopica 28:3, pages 221-232.
Crossref
Crossref
A.C.I.T.L. Tan, G. Den Hartog, J.W.R. Meijer, J.E. Thies, R.A. De Vries & C.J.J. Mulder. (2008)
No Additional Value of Bismuth Subcitrate to Combination Omeprazole/Amoxicillin Therapy in the Eradication of
Helicobacter pylori
. Helicobacter 2:4, pages 194-198.
Crossref
Crossref
Peter Unge. (1997) What Other Regimens Are Under Investigation to Treat Helicobacter pylori Infection?. Gastroenterology 113:6, pages S131-S148.
Crossref
Crossref
B E DunnH CohenM J Blaser. (1997) Helicobacter pylori. Clinical Microbiology Reviews 10:4, pages 720-741.
Crossref
Crossref
PI Reed & BJ Johnston. (1997) Treatment of helicobacter pylori infection. Biomedicine & Pharmacotherapy 51:1, pages 13-21.
Crossref
Crossref
C Stewart Goodwin, Michael M Mendall & Timothy C Northfield. (1997) Helicobacter pylori infection. The Lancet 349:9047, pages 265-269.
Crossref
Crossref
I. Rácz, Gy. Pécsi, A. Szabó & D. Varga. 1997. Cell Injury and Protection in the Gastrointestinal Tract. Cell Injury and Protection in the Gastrointestinal Tract
157
161
.
A W Harris, P A Gummett, J J Misiewicz & J H Baron. (1996) Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin.. Gut 38:5, pages 663-667.
Crossref
Crossref
D. Armstrong & R. H. Hunt. 1996. Helicobacter pylori. Helicobacter pylori
324
339
.
M. von Depka Prondzinski, A. Wenke, B. Braaden & I. Scharrer. 1996. 25. Hämophilie-Symposion Hamburg 1994. 25. Hämophilie-Symposion Hamburg 1994
338
343
.
J Parsonnet. (1995) Bacterial infection as a cause of cancer.. Environmental Health Perspectives 103:suppl 8, pages 263-268.
Crossref
Crossref
John H. Walsh & Walter L. Peterson. (1995)
The Treatment of
Helicobacter pylori
Infection in the Management of Peptic Ulcer Disease
. New England Journal of Medicine 333:15, pages 984-991.
Crossref
Crossref
GeoffreyM. Forbes, BrendanJ. Collins, Adam Harris, J.J. Misiewicz, Liam Murray & Ian Harvey. (1995) Helicobacter pylori: a human pathogen. The Lancet 345:8964, pages 1579-1580.
Crossref
Crossref
J. H. WALSH. (2008) Unanswered questions about Helicobacter pylori. Alimentary Pharmacology & Therapeutics 9, pages 31-37.
Crossref
Crossref
Mitsuro Chiba, Nobuaki Ishii, Tomonori Ishioka, Masahiko Murata, Osamu Masamune, Toshiro Sugiyama & Akira Yachi. (1995) Topographic study ofHelicobacter pylori and HLA-DR antigen expression on gastric epithelium. Journal of Gastroenterology 30:2, pages 149-155.
Crossref
Crossref
E M Witteman, M Mravunac, M J Becx, W P Hopman, J S Verschoor, G N Tytgat & R W de Koning. (1995) Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori.. Journal of Clinical Pathology 48:3, pages 250-256.
Crossref
Crossref
Pierre Michetti, Iréne Corthésy-Theulaz, Catherine Davin, Rainer Haas, Anne-Catherine Vaney, Madeleine Heitz, Jacques Bille, Jean-Pierre Kraehenbuhl, Emilia Saraga & AndréL. Blum. (1994) Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 107:4, pages 1002-1011.
Crossref
Crossref
Rudolf Hatz, Ekkehard Bayerdörffer, Norbert Lehn & Georg Enders. (2012) Immune Response in Helicobacter pylori Infection. Clinical Immunotherapeutics 2:4, pages 295-306.
Crossref
Crossref
J. G. PENSTON. (2007) Review article: Helicobacter pylori eradication–understandable caution but no excuse for inertia. Alimentary Pharmacology & Therapeutics 8:4, pages 369-389.
Crossref
Crossref
Nicholas J. Talley. (1994) A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 106:5, pages 1174-1183.
Crossref
Crossref
A. G. FRASER, R. SIM. E. A. SANKEY, A. P. DHILLON & R. E. POUNDER. (2007) Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Alimentary Pharmacology & Therapeutics 8:2, pages 167-173.
Crossref
Crossref
J. R. Lambert & S. K. Lin. 1994. Helicobacter pylori. Helicobacter pylori
95
112
.
K. Seppälä. 1994. Helicobacter pylori. Helicobacter pylori
429
436
.
P. Sipponen & K. Seppälä. 1994. Helicobacter pylori. Helicobacter pylori
372
380
.
H. L. WALDUM, E. BRENNA, P. M. KLEVELAND, A. K. SANDVIK & U. SYVERSEN. (2007) Review article: the use of gastric acid‐inhibitory drugs—physiological and pathophysiological considerations. Alimentary Pharmacology & Therapeutics 7:6, pages 589-596.
Crossref
Crossref
L A Noach, T M Rolf, N B Bosma, M P Schwartz, J Oosting, E A Rauws & G N Tytgat. (1993) Gastric metaplasia and Helicobacter pylori infection.. Gut 34:11, pages 1510-1514.
Crossref
Crossref
C GranbergA MansikkaO P LehtonenH KujariR GrönforsH NurmiI RäihäM R StåhlbergR Leino. (1993) Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies. Journal of Clinical Microbiology 31:6, pages 1450-1453.
Crossref
Crossref
Pekka A. Laurén & Timo J. Nevalainen. (1993) Epidemiology of intestinal and diffuse types of gastric carcinoma a time-trend study in finland with comparison between studies from high- and low-risk areas. Cancer 71:10, pages 2926-2933.
Crossref
Crossref
Marie E. Robert & Wilfred M. Weinstein. (1993) HELICOBACTER PYLORI–ASSOCIATED GASTRIC PATHOLOGY. Gastroenterology Clinics of North America 22:1, pages 59-72.
Crossref
Crossref
M.J. Arens & J. Dent. (1993) Acid pump blockers: what are their current therapeutic roles?. Baillière's Clinical Gastroenterology 7:1, pages 95-128.
Crossref
Crossref
Michael Mendall. 1993. Helicobacter pylori Infection. Helicobacter pylori Infection
21
32
.
John H. Walsh. (1992)
Helicobacter pylori
: Selection of Patients for Treatment
. Annals of Internal Medicine 116:9, pages 770-771.
Crossref
Crossref
T.U. Kosunen, K. Seppäla, S. Sarna & P. Sipponen. (1992) Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. The Lancet 339:8798, pages 893-895.
Crossref
Crossref
H RautelinK SeppäläO V RenkonenU VainioT U Kosunen. (1992) Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrobial Agents and Chemotherapy 36:1, pages 163-166.
Crossref
Crossref